Endocannabinoid levels in patients with Parkinson's disease with and without levodopa-induced dyskinesias.

MLA

Marchioni, Camila, et al. “Endocannabinoid Levels in Patients with Parkinson’s Disease with and without Levodopa-Induced Dyskinesias.” Journal of Neural Transmission (Vienna, Austria : 1996), vol. 127, no. 10, Oct. 2020, pp. 1359–67. EBSCOhost, https://doi.org/10.1007/s00702-020-02240-9.

APA

Marchioni, C., Santos-Lobato, B. L., Queiroz, M. E. C., Crippa, J. A. S., & Tumas, V. (2020). Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias. Journal of Neural Transmission (Vienna, Austria : 1996), 127(10), 1359–1367. https://doi.org/10.1007/s00702-020-02240-9

Chicago

Marchioni, Camila, Bruno Lopes Santos-Lobato, Maria Eugênia Costa Queiroz, José Alexandre S Crippa, and Vitor Tumas. 2020. “Endocannabinoid Levels in Patients with Parkinson’s Disease with and without Levodopa-Induced Dyskinesias.” Journal of Neural Transmission (Vienna, Austria : 1996) 127 (10): 1359–67. doi:10.1007/s00702-020-02240-9.